LC
Lipi Chatterjee
About Lipi Chatterjee
Data last updated:
Lipi Chatterjee is a Director at Rhine Pharma Private Limited (since 2024) and Designated Partner at Riel Pharma Llp (since 2022). The companies operate in Paper and Chemicals.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Oct 2024 | 2024 | Active | ||
| Designated Partner | 26 Dec 2022 | 2021 | Active |
Board colleagues of Lipi Chatterjee
| Name | DIN | Company | Designation |
|---|---|---|---|
| Seikh Fayejul Bary | 11368030 | Rhine Pharma Private Limited | Director |
| Sk Rejaul Bari | 09172051 | Riel Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Lipi Chatterjee
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lipi Chatterjee
Lipi Chatterjee currently holds 2 directorships: Rhine Pharma Private Limited (Director, since 23 Oct 2024); Riel Pharma Llp (Designated Partner, since 26 Dec 2022).
Lipi Chatterjee was first appointed on 26 Dec 2022 as Designated Partner at Riel Pharma Llp. The most recent appointment on record is 23 Oct 2024 at Rhine Pharma Private Limited.
The current boards of Lipi Chatterjee's companies include Seikh Fayejul Bary (Rhine Pharma Private Limited), Sk Rejaul Bari (Riel Pharma Llp).